FunPep Company Limited (4881.T)
JPY 131.0
(0.77%)
JPY 131.0
(0.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -680.28 Million JPY | 25.35% |
| 2022 | -911.28 Million JPY | -70.14% |
| 2021 | -535.62 Million JPY | -47.96% |
| 2020 | -362.01 Million JPY | -225.6% |
| 2019 | 288.22 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -98.39 Million JPY | 16.43% |
| 2024 Q2 | -10.46 Million JPY | 89.36% |
| 2023 Q2 | -156.38 Million JPY | 46.88% |
| 2023 Q4 | -117.73 Million JPY | -5.32% |
| 2023 Q1 | -294.37 Million JPY | -2583.69% |
| 2023 FY | -680.28 Million JPY | 25.35% |
| 2023 Q3 | -111.79 Million JPY | 28.51% |
| 2022 Q3 | 184 Thousand JPY | 0.0% |
| 2022 FY | -911.28 Million JPY | -70.14% |
| 2022 Q4 | -10.96 Million JPY | -6061.41% |
| 2021 FY | -535.62 Million JPY | -47.96% |
| 2020 FY | -362.01 Million JPY | -225.6% |
| 2019 FY | 288.22 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 136.161% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | 947.119% |
| GNI Group Ltd. | 22.43 Billion JPY | 103.033% |
| Linical Co., Ltd. | 3.77 Billion JPY | 118.005% |
| Trans Genic Inc. | 2.24 Billion JPY | 130.245% |
| MEDINET Co., Ltd. | 98.25 Million JPY | 792.39% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 127.405% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 152.629% |
| AnGes, Inc. | -3.06 Billion JPY | 77.807% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | -282.79% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 107.039% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 231.509% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 713.114% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 146.897% |
| CanBas Co., Ltd. | -984 Million JPY | 30.865% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 273.676% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 141.076% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 270.671% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 165.451% |
| PeptiDream Inc. | 17.21 Billion JPY | 103.951% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | 2322.797% |
| Ribomic Inc. | -10.5 Million JPY | -6377.69% |
| SanBio Company Limited | -14.5 Million JPY | -4590.341% |
| Healios K.K. | 108 Million JPY | 729.895% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | -199397.654% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | -1052.131% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | -44892.526% |
| StemRIM | -44.34 Million JPY | -1433.94% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 121.359% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 1082.364% |
| Stella Pharma Corporation | 217.29 Million JPY | 413.066% |
| TMS Co., Ltd. | -6.95 Million JPY | -9688.302% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 316.266% |
| Cuorips Inc. | 9.63 Million JPY | 7163.514% |
| K Pharma,Inc. | 910 Million JPY | 174.757% |
| Takara Bio Inc. | 25.45 Billion JPY | 102.672% |
| ReproCELL Incorporated | 1.1 Billion JPY | 161.58% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 156.925% |
| StemCell Institute Inc. | 1.57 Billion JPY | 143.169% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 140.814% |
| CellSeed Inc. | 107.15 Million JPY | 734.863% |